phenobarbital sodium msds - An Overview
phenobarbital sodium msds - An Overview
Blog Article
pentobarbital will lower the level or effect of alprazolam by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep track of.
pentobarbital will lessen the extent or effect of eltrombopag by impacting hepatic enzyme CYP2C9/ten metabolism. Use Warning/Monitor.
pentobarbital decreases levels of vandetanib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Stay clear of coadministration with powerful CYP3A4 inducers; these drugs reduce publicity to vandetanib by as much as forty%.
pentobarbital will decrease the extent or effect of fentanyl transmucosal by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Monitor Intently. Coadministration of fentanyl with CYP3A4 inducers may lead to some minimize in fentanyl plasma concentrations, deficiency of efficacy or, quite possibly, enhancement of a withdrawal syndrome inside of a affected individual who's got produced Actual physical dependence to fentanyl.
pentobarbital will lessen the extent or effect of stiripentol by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Prevent or Use Alternate Drug. If not able to stay away from coadministration of stiripentol with powerful CYP3A4 inducers, increase stiripentol dose.
pentobarbital will lower the level or effect of fentanyl transdermal by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Check Carefully. Coadministration of fentanyl with CYP3A4 inducers may lead to your minimize in fentanyl plasma concentrations, not enough efficacy or, probably, advancement of a withdrawal syndrome inside of a patient who has developed Actual physical dependence to fentanyl.
Specific patient population: Dosage must be reduced while in the aged or debilitated simply because these sufferers may be a lot more sensitive to barbiturates. Dosage really should be reduced for people with impaired renal here function or hepatic illness.
pentobarbital will decrease the extent or effect of sufentanil by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Importance Mysterious.
fentanyl iontophoretic transdermal technique and pentobarbital both equally boost sedation. Steer clear of or Use Alternate Drug. Restrict use to clients for whom alternative treatment method options are inadequate
pentobarbital will lower the extent or effect of loratadine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Monitor.
pentobarbital will decrease the level or effect of piroxicam by affecting hepatic enzyme CYP2C9/10 metabolism. Minor/Significance Unidentified.
pentobarbital improves effects of ifosfamide by impacting hepatic enzyme CYP2B6 metabolism. Use Warning/Observe. Coadministration of ifosfamide with CYP2B6 inducers may well enhance metabolism of ifosfamide to its metabolite. Keep track of for increased effects/toxicities if put together with CYP2B6 inducers.
pentobarbital will decrease the level or effect of elbasvir/grazoprevir by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. The therapeutic effect of elbasvir/grazoprevir may very well be minimized if coadministered with sturdy CYP3A inducers and it is consequently contraindicated.
Facts in rodents As well as in primates counsel that the neuronal and oligodendrocyte cell losses are associated with delicate but extended cognitive deficits in Understanding and memory. The medical importance of those nonclinical conclusions is just not regarded, and Health care providers need to harmony some great benefits of correct anesthesia in neonates and youthful children who require methods towards the opportunity challenges proposed from the nonclinical facts (see “Warnings-Pediatric Neurotoxicity” and “Precautions-Pregnancy and Pediatric Use”). AKORN